Accès gratuit
Numéro
Med Sci (Paris)
Volume 18, Numéro 3, Mars 2002
Page(s) 353 - 356
Section M/S Revues : Mini-Synthèses
DOI http://dx.doi.org/10.1051/medsci/2002183353
Publié en ligne 15 mars 2002
  1. Consensus statement. EASL International Consensus Conference on Hepatitis C. J Hepatol 1999; 30 : 956–61.
  2. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology 2000; 32 : 477–81.
  3. Rayssiguier R, Bonny C, Abergel A, et al. Pratiques et attentes des médecins généralistes en matière d’hépatite C dans la région Auvergne. Gastroenterol Clin Biol 2001; 25 : A67 (abstract).
  4. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000; 14 : 543–8.
  5. Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection : a prospective study. Lancet 2001; 357 : 1069–75.
  6. Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996; 42 : 558–63.
  7. Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113 : 1609–16.
  8. Tiggelman AM, Boers W, Moorman AF, et al. Localization of alpha 2-macroglobulin protein and messenger RNA in rat liver fibrosis: evidence for the synthesis of alpha 2-macroglobulin within Schistosoma mansoni egg granulomas. Hepatology 1996; 23 : 1260–7.
  9. Tiggelman AM, Linthorst C, Boers W, Brand HS, Chamuleau RA. Transforming growth factorbeta-induced collagen synthesis by human liver myofibroblasts is inhibited by alpha2-macroglobulin. J Hepatol 1997; 26 : 1220–8.
  10. Naveau S, Poynard T, Benattar C, Bedossa P, Chaput JC. Alpha-2-macroglobulin and hepatic fibrosis. Diagnostic interest. Dig Dis Sci 1994; 39 : 2426–32.
  11. Meisse D, Renouf S, Husson A, Lavoinne A. Cell swelling increased the alpha2-macroglobulin gene expression in cultured rat hepatocytes. FEBS Lett 1998; 422 : 346–8.
  12. Kawser CA, Iredale JP, Winwood PJ, Arthur MJ. Rat hepatic stellate cell expression of alpha2-macroglobulin is a feature of cellular activation: implications for matrix remodelling in hepatic fibrosis. Clin Sci 1998; 95 : 179–86.
  13. Bacq Y, Schillio Y, Brechot JF, De Muret A, Dubois F, Metman EH. Decrease of haptoglobin serum level in patients with chronic viral hepatitis C. Gastroenterol Clin Biol 1993; 17 : 364–9.
  14. Louagie HK, Brouwer JT, Delanghe JR, De Buyzere ML, Leroux-Roels GG. Haptoglobin polymorphism and chronic hepatitis C. J Hepatol 1996; 25 : 10–4.
  15. Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5 : 226–30.
  16. Guillen MI, Gomez-Lechon MJ, Nakamura T, Castell JV. The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: divergent effect on interleukin-6-stimulated genes. Hepatology 1996; 23 : 1345–52.
  17. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997; 181 : 257–66.
  18. Paradis V, Laurent A, Mathurin P, et al. Role of liver extracellular matrix in transcriptional and post-transcriptional regulation of apolipoprotein A-I by hepatocytes. Cell Mol Biol 1996; 42 : 525–34.
  19. Edwards AM, Lucas CM, Baddams HM. Modulation of gamma-glutamyltranspeptidase in normal rat hepatocytes in culture by cell density, epidermal growth factor and agents which alter cell differentiation. Carcinogenesis 1987; 8 : 1837–42.
  20. Poynard T, Imbert-Bismut F, Ratziu V, et al Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepatitis 2002 (sous presse).